Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
---|---|---|---|---|---|---|
Filed 2022-07-21 22:40 Tx date 2022-07-18 |
$PREV
PreveCeutical Medical Inc. |
Van Deventer, Kimberly
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$50,000
+2,000,000 vol $0.025 each |
3,250,000 | |
Filed 2020-01-27 18:15 Tx date 2020-01-23 |
$
Straightup Resources Inc. |
Van Deventer, Kimberly
3 - 10% Security Holder of Issuer
Direct Ownership
|
Warrants
00 - Opening Balance-Initial SEDI Report
|
1,125,000 | ||
Filed 2020-01-27 18:12 Tx date 2020-01-23 |
$
Straightup Resources Inc. |
Van Deventer, Kimberly
3 - 10% Security Holder of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
1,125,000 | ||
Filed 2019-02-14 Tx date 2019-02-14 |
$PREV
PreveCeutical Medical Inc. (formerly, Carrara Exploration Corp.) |
Van Deventer, Kimberly
4 - Director of Issuer
Direct Ownership
|
Convertible Debt Securities
37 - Stock split or consolidation
|
+933,332 vol |
11,583,332 | |
Filed 2019-02-14 Tx date 2019-01-15 |
$PREV
PreveCeutical Medical Inc. (formerly, Carrara Exploration Corp.) |
Van Deventer, Kimberly
4 - Director of Issuer
Direct Ownership
|
Convertible Debt Securities
56 - Grant of rights
|
+10,416,667 vol |
10,650,000 | |
Filed 2018-08-09 Tx date 2018-05-24 |
$PREV
PreveCeutical Medical Inc. (formerly, Carrara Exploration Corp.) |
Van Deventer, Kimberly
4 - Director of Issuer
Direct Ownership
|
Common Shares Without Par Value or Special Rights or Restrictions attached
37 - Stock split or consolidation
|
+28,000,000 vol |
35,000,000 | |
Filed 2018-08-09 Tx date 2018-05-24 |
$PREV
PreveCeutical Medical Inc. (formerly, Carrara Exploration Corp.) |
Van Deventer, Kimberly
4 - Director of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
$50,000
+1,000,000 vol $0.05 each |
1,250,000 | |
Filed 2018-08-02 Tx date 2018-08-02 |
$PREV
PreveCeutical Medical Inc. (formerly, Carrara Exploration Corp.) |
Van Deventer, Kimberly
4 - Director of Issuer
Direct Ownership
|
Common Shares Without Par Value or Special Rights or Restrictions attached
10 - Acquisition or disposition in the public market
|
$52,500
+1,500,000 vol $0.035 each |
8,500,000 | |
Filed 2018-04-24 Tx date 2017-05-19 |
$PREV
PreveCeutical Medical Inc. (formerly, Carrara Exploration Corp.) |
Van Deventer, Kimberly
4 - Director of Issuer
Direct Ownership
|
Convertible Debt Securities
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2018-04-24 Tx date 2018-03-28 |
$PREV
PreveCeutical Medical Inc. (formerly, Carrara Exploration Corp.) |
Van Deventer, Kimberly
4 - Director of Issuer
Direct Ownership
|
Convertible Debt Securities
56 - Grant of rights
|
+140,000 vol |
140,000 | |
Filed 2018-04-24 Tx date 2018-04-20 |
$PREV
PreveCeutical Medical Inc. (formerly, Carrara Exploration Corp.) |
Van Deventer, Kimberly
4 - Director of Issuer
Direct Ownership
|
Convertible Debt Securities
56 - Grant of rights
|
+93,333 vol |
233,333 | |
Filed 2017-07-07 Tx date 2017-06-30 |
$PREV
PreveCeutical Medical Inc. (formerly, Carrara Exploration Corp.) |
Van Deventer, Kimberly
4 - Director of Issuer
Direct Ownership
|
Common Shares Without Par Value or Special Rights or Restrictions attached
22 - Acquisition or disposition pursuant to a take-over bid, merger or acquisition
|
$3,500,000
+7,000,000 vol $0.50 each |
7,000,000 | |
Filed 2017-07-07 Tx date 2017-05-19 |
$PREV
PreveCeutical Medical Inc. (formerly, Carrara Exploration Corp.) |
Van Deventer, Kimberly
4 - Director of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
|||
Filed 2017-07-07 Tx date 2017-06-30 |
$PREV
PreveCeutical Medical Inc. (formerly, Carrara Exploration Corp.) |
Van Deventer, Kimberly
4 - Director of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
+250,000 vol |
250,000 | |
Filed 2017-06-30 Tx date 2017-05-19 |
$CAA
Carrara Exploration Corp. |
Van Deventer, Kimberly
4 - Director of Issuer
Direct Ownership
|
Common Shares Without Par Value or Special Rights or Restrictions attached
00 - Opening Balance-Initial SEDI Report
|